|
l Contract research in drug discovery using leading-edge rational drug design software.
l Rational drug design services or as software packages.
l In-house drug discovery projects using the proprietary rational drug design technologies; development of IκB kinase β inhibitors
l IMMD offers contract research on mechanism of action of drug candidates, target discovery, and target validation etc., using KeyTarget technology which assesses the effects of drugs on key proteins.
l KeyMolnet-the world's first bioinformatics system which systemizes and consolidates information on various important biological subjects such as molecules, biological phenomena, diseases, drugs and gene mutations etc. using the proprietary linkage technology developed by IMMD. |